WO1996025096A1 - Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules - Google Patents

Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules Download PDF

Info

Publication number
WO1996025096A1
WO1996025096A1 PCT/US1996/002092 US9602092W WO9625096A1 WO 1996025096 A1 WO1996025096 A1 WO 1996025096A1 US 9602092 W US9602092 W US 9602092W WO 9625096 A1 WO9625096 A1 WO 9625096A1
Authority
WO
WIPO (PCT)
Prior art keywords
template
sample
paced
pacing
electrode
Prior art date
Application number
PCT/US1996/002092
Other languages
English (en)
Other versions
WO1996025096A9 (fr
Inventor
David K. Swanson
James G. Whayne
Dorin Panescu
Original Assignee
Ep Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/393,158 external-priority patent/US5711305A/en
Application filed by Ep Technologies, Inc. filed Critical Ep Technologies, Inc.
Publication of WO1996025096A1 publication Critical patent/WO1996025096A1/fr
Publication of WO1996025096A9 publication Critical patent/WO1996025096A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25—Bioelectric electrodes therefor
    • A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283—Invasive
    • A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/35—Detecting specific parameters of the electrocardiograph cycle by template matching
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852—Catheters
    • A61B5/6855—Catheters with a distal curved tip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852—Catheters
    • A61B5/6858—Catheters with a distal basket, e.g. expandable basket
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/005—Flexible endoscopes
    • A61B1/0051—Flexible endoscopes with controlled bending of insertion part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04—Arrangements of multiple sensors of the same type
    • A61B2562/043—Arrangements of multiple sensors of the same type in a linear array

Definitions

  • the invention relates to systems and meth ⁇ ods for acquiring, measuring, and analyzing electro ⁇ cardiograms. Bacfc ⁇ round of the Invention
  • SA node 10 with the sinoatrial node (or "SA node") generating a depolarization wave front.
  • the impulse causes adjacent myocardial tissue cells in the atria to depolarize, which in turn causes adjacent myocardial tissue cells to depolarize.
  • AV node atrioventricular node
  • HIS HIS bundle
  • ischemic myocardial tissue may propagate depolarization events slower than normal myocardial tissue.
  • the ischemic region also called a “slow conduction zone,” creates errant, circular propagation patterns, called “circus motion.”
  • the circus motion also disrupts the normal depolariza ⁇ tion patterns, thereby disrupting the normal con ⁇ traction of heart tissue.
  • the aberrant conductive pathways create abnormal, irregular, and sometimes life-threatening heart rhythms, called arrhythmias.
  • An arrhythmia can take place in the atria, for example, as in atrial tachycardia (AT) or atrial flutter (AF) .
  • the arrhythmia can also take place in the ventricle, for example, as in ventricular tachycardia (VT) .
  • the location of the sources of the aberrant pathways (call foci) be located. Once located, the tissue in the foci can be destroyed, or ablated, by heat, chemicals, or other means. Ablation can remove the aberrant conductive pathway, restoring normal myocardial contraction.
  • paced electrograms Today, physicians examine the propagation of electrical impulses in heart tissue to locate aberrant conductive pathways. The techniques used to analyze these pathways, commonly called “mapping,” identify regions in the heart tissue, called foci, which can be ablated to treat the arrhythmia.
  • One form of conventional cardiac tissue mapping techniques uses multiple electrodes posi ⁇ tioned in contact with epicardial heart tissue to obtain multiple electrograms. The physician stimu ⁇ lates myocardial tissue by introducing pacing sig- nals and visually observes the morphologies of the electrograms recorded during pacing, which this Specification will refer to as "paced electrograms.” The physician visually compares the patterns of paced electrograms to those previously recorded during an arrhythmia episode to locate tissue regions appropriate for ablation.
  • the physician In searching for the VT foci, the physician must visually compare all paced electrocardiograms (recorded by twelve lead body surface electrocardiograms (ECG's)) to those previously recorded during an induced VT. The physician must constantly relocate the roving electrode to a new location to systematically map the endocardium.
  • ECG's lead body surface electrocardiograms
  • artifacts caused by the pacing signals can distort the electrocardiograms.
  • the pacing artifacts can mask the beginning of the Q- wave in the electrocardiogram.
  • the morphology of the pacing artifact visually differs from the morphology of the electro ⁇ cardiogram.
  • a trained physician is therefore able to visually differentiate between a pacing artifact and the electrocardiogram morphology. This is not always the case in endocardial or epicardial map ⁇ ping, in which there can be a very close similarity between the morphology of the pacing artifact and the bipolar electrogram morphology.
  • the pacing artifact and electrogram complex are separated in time, and therefore can be distinguished from one another by a trained physi ⁇ cian.
  • the presence of the pacing artifact can sometimes mask the entire bipolar electrogram.
  • its likeness to the bipolar electrogram often makes it difficult or impossible for even a trained physician to detect the beginning of depolarization with accuracy.
  • a principal objective of the invention is to provide improved systems and methods to quickly and accurately examine heart tissue morphology using electrocardiograms.
  • One aspect of the invention provides sys ⁇ tems and methods for acquiring electrocardiograms.
  • the systems and methods use first and second elec ⁇ trodes.
  • An element supports the first electrode for operative association with a region of heart tissue, while another element supports the second electrode for operative association with a region of body surface tissue.
  • An analog or digital processing element is coupled to the first and second electrode for conditioning the first electrode to emit a pacing signal and for conditioning the second electrode to sense paced electrocardiograms occur- ring as a result of the pacing signal.
  • the first electrode can be in operative association either with endocardial tissue or with epicardial tissue.
  • the systems and methods employ a template of an electrocardiogram of a cardiac event of known diagnosis.
  • the selected event comprises an arrhythmia that the physician seeks to treat, for example, ventricular tachycardia (VT) , or atrial tachycardia (AT) , or atrial fibrillation (AF) .
  • the systems and methods compare this event-specific template to a sample of a paced electrocardiogram.
  • entrainment pacing is used.
  • Pace mapping can also be implemented. The comparison yields an output .
  • the output comprises a matching coefficient indicating how alike the input sample is to the input template.
  • the matching coefficient can be used by the physi ⁇ cian, for example, to aid in the location of sites that are potentially appropriate for ablation.
  • a matching coefficient that indicates close similarity between the sample and the template suggests that the pacing site lies close to a region appropriate for ablation to treat the arrhythmia.
  • the systems and methods employ various alternative methods for comparing the template to the paced sample.
  • Various alternative embodiments employ matched filtering, cross correlation, and norm of the difference techniques.
  • the paced sample is compared to the input template by using the input template to create a matched filtered sample and by analyzing the symmetry of the matched filtered sample.
  • Another aspect of the invention provides systems and methods for analyzing electrocardiograms for the purpose of assessing cardiac tissue morphol ⁇ ogy.
  • the systems and methods employ an analog or digital processing element electrically coupled to the first electrode and second body surface elec ⁇ trode.
  • the processing element conditions the first electrode to emit a pacing signal at or near sinus rhythm rate, while recording paced sinus rhythm electrocardiograms including a Q-wave sensed by the second electrode.
  • the processing element derives from the electrocardiograms a first time difference between the pacing signal and the sensed Q-wave.
  • the processing element also conditions the first elec- trode to emit a pacing signal at an increased rate, greater than sinus rhythm rate, while recording in ⁇ creased rate paced electrocardiograms sensed by the second electrode to derive a second time difference between the pacing signal and the sensed Q-wave.
  • the processing element compares the first time difference to the second time difference and gener ⁇ ating an output based upon the comparison.
  • the output can be used to assess cardiac tissue viabili ⁇ ty. For example, in a preferred embodiment, the output identifies increases or decreases in the second time difference, when compared to the first time difference. These changes can be used to aid in the location of regions of ischemic tissue potentially appropriate for ablation.
  • FIG. 1A is a diagrammatic view of a system, which embodies the features of the invention, for accessing a targeted tissue region in the body for diagnostic or therapeutic purposes;
  • Fig. IB is a diagrammatic view of the system shown in Fig. 1A, with the inclusion of a roving pacing probe and additional features to aid the physician in conducting diagnosis and therapeu ⁇ tic techniques according to the invention;
  • Fig. 2 is an enlarged perspective view of a multiple-electrode structure used in association with the system shown in Fig. 1;
  • Fig. 3 is an enlarged view of an ablation probe usable in association with the system shown in Figs. 1A and IB;
  • Fig. 4A is a diagrammatic view of the process controller shown in Figs. 1A and IB, which locates by electrogram matching a site appropriate for ablation;
  • Fig. 4B is a schematic view of a slow conduction zone in myocardial tissue and the circu ⁇ lar propagation patterns (called circus motion) it creates;
  • Fig. 5 is a flow chart showing a pattern matching technique that the process controller shown in Fig. 4A can employ for matching electrograms according to the invention
  • Figs. 6A to 6E are representative electro ⁇ gram morphologies processed in accordance with the pattern matching technique shown in Fig. 5;
  • Figs. 7A and 7B are, respectively, a flow chart and illustrative wave shape showing a symmetry matching technique that the process controller shown in Fig. 4A can employ for matching electrograms according to the invention;
  • Figs. 8A to 8C are representative electro ⁇ gram morphologies processed in accordance with the symmetry matching technique shown in Fig. 7A;
  • Fig. 9 is a flow chart showing a matched filtering technique that the process controller shown in Fig. 4A can employ for matching electrograms according to the invention
  • Fig. 10 is a flow chart showing a cross correlation coefficient technique that the process controller shown in Fig. 4A can employ for matching electrograms according to the invention
  • Figs. 11A and 11B are representative elec ⁇ trogram morphologies processed in accordance with the cross correlation coefficient technique shown in Fig. 10;
  • Fig. 12 is a flow chart showing a norm of the difference technique that the process controller shown in Fig. 4A can employ for matching electrograms according to the invention;
  • Figs. 13A and 13B are representative elec- trogram morphologies processed in accordance with the norm of the difference technique shown in Fig. 12;
  • Fig. 14A is a flow chart showing a filter ⁇ ing technique that the process controller shown in Fig. 4A can employ for removing pacing artifacts according to the invention
  • Fig. 14B is a diagram showing the implemen ⁇ tation of the filtering technique shown in Fig. 14A as a median filter
  • Fig. 14C is a diagram showing the implemen ⁇ tation of the filtering technique shown in Fig. 14A as a non-median filter
  • Fig. 15A to D; 16A to D; 17A to D are representative electrogram morphologies showing the effect of the sort position selection criteria in removing the pacing artifact employing the technique shown in Fig. 14;
  • Figs. 18A to C are representative elec ⁇ trogram morphologies showing the effect of the sample window size in removing the pacing artifact employing the technique shown in Fig. 14;
  • Fig. 19 is a diagrammatic view of an adap ⁇ tive filtering technique that the process controller shown in Fig. 4A can employ for removing pacing artifacts according to the invention
  • Figs. 20A and 2OB are representative elec ⁇ trogram morphologies processed by the adaptive filtering technique shown in Fig. 19 to remove a pacing artifact
  • Fig. 21 is a diagrammatic flow chart showing the operation of the time-sequential mode of the process controller shown in Fig. 1 in creating an electrogram composite over different time inter ⁇ vals
  • Figs. 22A to 22D show representative individual electrograms taken at different time intervals during the time-sequential mode shown in Fig. 21, before time-alignment;
  • Figs. 23A to 23D show the representative individual electrograms shown in Figs. 22A to 22D, after time-alignment, to form the electrogram composite;
  • Fig. 24 shows a pace electrogram with three pacing artifacts, before adaptive filtering
  • Figs. 25A to C show the artifact signals of the three pacing artifacts shown in Fig. 24, manual ⁇ ly selected by the physician, before alignment and truncation;
  • Figs. 26A to C show the artifact signals of the three pacing artifacts shown in Fig. 25 A to C, after alignment and truncation;
  • Fig. 27 shows the artifact template that results from averaging the three artifact signals shown in Figs. 26A to C; and Figs. 28A and B show the alignment of the first pacing artifact (in Fig. 28A) with the arti ⁇ fact template (in Fig. 28B) .
  • Fig. 1A shows the components of a system 10 for analyzing body tissue biopotential morphologies for diagnostic or therapeutic purposes.
  • the illus- trated embodiment shows the system 10 being used to examine the depolarization of heart tissue that is subject to an arrhythmia.
  • the system 10 serves to locate an arrhythmogenic focus for removal by ablation.
  • the invention is well suited for use in conducting electrical therapy of the heart.
  • the invention is applicable for use in other regions of the body where tissue biopotential morphologies can be ascertained by analyzing electrical events in the tissue.
  • tissue biopotential morphologies can be ascertained by analyzing electrical events in the tissue.
  • the various aspects of the invention have application in procedures for analyz ⁇ ing brain or neurologic tissue.
  • Fig. 1A shows the system 10 analyzing endocardial electrical events, using catheter-based, vascular access techniques. Still, many aspects of the invention can be used in association with techniques that do not require any intrusion into the body, like surface electrocardiograms or elec- troencephalograms. Many of the aspects of the invention also can be used with invasive surgical techniques, like in open chest or open heart sur ⁇ gery, or during brain surgery.
  • FIG. 1A shows the system 10 analyzing electrical events within a selected region 12 inside a human heart.
  • Figs. 1A and IB generally show the system 10 deployed in the left ventricle of the heart. Of course, the system 10 can be deployed in other regions of the heart, too. It should also be noted that the heart shown in the Fig. 1 is not anatomically accurate.
  • Figs. 1A and IB show the heart in diagrammatic form to demonstrate the features of the invention.
  • the system 10 includes a mapping probe 14 and an ablation probe 16.
  • each is sepa ⁇ rately introduced into the selected heart region 12 through a vein or artery (typically the femoral vein or artery) through suitable percutaneous access.
  • the mapping probe 14 and ablation probe 16 can be assembled in an integrated structure for simultaneous introduction and deployment in the heart region 12.
  • the mapping probe 14 has a flexible cathe ⁇ ter body 18.
  • the distal end of the catheter body 18 carries a three dimensional multiple-electrode structure 20.
  • the structure 20 takes the form of a basket defining an open interior space 22 (see Fig. 2) . It should be appreciated that other three dimensional structures could be used.
  • the illustrated basket structure 20 comprises a base member 26 and an end cap 28.
  • Generally flexible splines 30 extend in a circumferentially spaced relationship between the base member 26 and the end cap 28.
  • the splines 30 are preferably made of a resilient, biologically inert material, like Nitinol metal or silicone rubber.
  • the splines 30 are con- nected between the base member 26 and the end cap 28 in a resilient, pretensed, radially expanded con ⁇ dition, to bend and conform to the endocardial tissue surface they contact.
  • eight splines 30 form the basket structure 20. Additional or fewer splines 30 could be used.
  • the splines 30 carry an array of electrodes 24.
  • each spline 30 carries eight electrodes 24.
  • additional or fewer electrodes 24 can be used.
  • a slidable sheath 19 is movable along the axis of the catheter body 18 (shown by arrows in Fig. 2) . Moving the sheath 19 forward causes it to move over the basket structure 20, collapsing it into a compact, low profile condition for introduc ⁇ ing into the heart region 12. Moving the sheath 19 rearward frees the basket structure 20, allowing it to spring open and assume the pretensed, radially expanded position shown in Fig. 2. The electrodes are urged into contact against the surrounding heart tissue.
  • the electrodes 24 sense electrical events in myocardial tissue for the creation of electrograms.
  • the electrodes 24 are electrically coupled to a process controller 32 (see Fig. 1A) .
  • a signal wire (not shown) is electrically coupled to each electrode 24.
  • the wires extend through the body 18 of the probe 14 into a handle 21, in which they are coupled to an external multiple pin connec- tor 23.
  • the connector 23 electrically couples the electrodes to the process controller 32.
  • multiple electrode struc ⁇ tures can be located epicardially using a set of catheters individually introduced through the coronary vasculature (e.g., retrograde through the aorta or coronary sinus) , as disclosed in PCT/US94/01055 entitled “Multiple Intravascular Sensing Devices for Electrical Activity.”
  • the ablation probe 16 (see Fig. 3) includes a flexible catheter body 34 that carries one or more ablation electrodes 36. For the sake of illustra ⁇ tion. Fig. 3 shows a single ablation electrode 36 carried at the distal tip of the catheter body 34. Of course, other configurations employing multiple ablation electrodes are possible, as described in pending U.S. Patent Application Serial No. 08/287,310, filed August 8, 1994, entitled “Systems and Methods for Ablating Heart Tissue Using Multiple Electrode Elements.” A handle 38 is attached to the proximal end of the catheter body 34.
  • the handle 38 and catheter body 34 carry a steering mechanism 40 for selec ⁇ tively bending or flexing the catheter body 34 along its length, as the arrows in Fig. 3 show.
  • the steering mechanism 40 can vary.
  • the steering mechanism can be as shown in U.S. Patent 5,254,088, which is incorporated herein by reference.
  • a wire (not shown) electrically connected to the ablation electrode 36 extends through the catheter body 34 into the handle 38, where it is electrically coupled to an external connector 45.
  • the connector 45 connects the electrode 36 to a generator 46 of ablation energy.
  • the type of energy used for ablation can vary.
  • the genera- tor 46 supplies electromagnetic radio frequency energy, which the electrode 36 emits into tissue.
  • a radio frequency generator Model EPT-1000, available from EP Technologies, Inc., Sunnyvale, California, can be used for this purpose.
  • the physician places the ablation electrode 36 in contact with heart tissue at the site identified for ablation.
  • the ablation electrode emits ablating energy to heat and thermally destroy the contacted tissue.
  • the process controller 32 employs electrogram matching to automatically locate for the physician the site or sites potentially appropriate for abla- tion.
  • the process controller 32 is operable to sense electrical events in heart tissue and to process and analyze these events to achieve the objectives of the invention.
  • the process controller 32 is also selectively operable to induce electrical events by transmitting pacing signals into heart tissue.
  • the process controller 32 is electrically coupled by a bus 47 to a pacing module 48, which paces the heart sequentially through individual or pairs of electrodes to induce depolar ⁇ ization.
  • a pacing module 48 which paces the heart sequentially through individual or pairs of electrodes to induce depolar ⁇ ization. Details of the process controller 32 and pacing module 48 are described in copending U.S. Patent Application Serial No. 08/188,316, filed January 28, 1994, and entitled "Systems and Methods for Deriving Electrical Characteristics of Cardiac Tissue for Output in Iso-Characteristic Displays.”
  • the process controller 32 is also electrically coupled by a bus 49 to a signal processing module 50.
  • the processing module 50 processes cardiac signals into electrograms.
  • a Model TMS 320C31 processor available from Spectrum Signal Processing, Inc. can be used for this purpose.
  • the process controller 32 is further electrical- ly coupled by a bus 51 to a host processor 52, which processes the input from the electrogram processing module 50 in accordance with the invention to locate arrhythmogenic foci.
  • the host processor 32 can comprise a 486-type microprocessor. According to the invention, the process con ⁇ troller 32 operates in two functional modes, called the sampling mode and the matching mode.
  • the physician deploys the basket structure 20 in the desired heart region 12.
  • the physician may have to collapse the basket structure 20, rotate it, and then free the basket structure 20.
  • the degree of contact can be sensed by the process controller 32 in various ways.
  • the process controller 32 can condition the pacing module 48 to emit pacing signals through a selected electrode 24 or pair of electrodes 24.
  • the process controller 32 conditions the electrodes 24 and processing module 50 to detect electrograms sensed by a desired number of the electrodes 24.
  • the processing module can also ascertain the desired degree of contact by measuring tissue impedance, as described in copending patent application Serial No. 08/221,347, filed March 31, 1994, and entitled "Systems and Methods for Positioning Multiple Electrode Structures in Electrical Contact with the Myocardium.”
  • the process controller 32 conditions the electrodes 24 and signal processing module 50 to record electrograms during a selected cardiac event having a known diagnosis. In the sampling mode, the process controller 32 typically must condition the pacing module 48 to pace the heart until the desired cardiac event is induced. Of course, if the patient spontaneously experiences the cardiac event while the structure 20 is positioned, then paced-induction is not required.
  • the processor controller 32 saves these electrograms in the host processor 52.
  • the process controller 32 creates templates of selected electrogram morphologies by any conventional method, e.g., by having the physician manually select representative electrogram morphologies.
  • the process controller 32 typically must condition the pacing module 48 to pace terminate the cardiac event, or the physician may apply a shock to restore normal sinus rhythm.
  • the matching mode is conducted without altering the position of the multiple electrode structure 20 in the heart region 12, so that the electrodes 24 occupy the same position during the matching mode as they did during the sampling mode.
  • the process controller 32 conditions the pacing module 48 to pace the heart in a prescribed manner without inducing the cardiac event of interest, while conditioning the signal processing module 50 to record the resulting electrograms.
  • the process controller 32 operates the host processor 52 to compare the resulting paced electrogram morphologies to the electrogram morphol ⁇ ogy templates collected during the sampling mode. Based upon this comparison, the host processor 52 generates an output that identifies the location of the electrode or electrodes 24 on the structure 20 that are close to a potential ablation site. ⁇ .
  • the process con ⁇ troller 32 operates in the sampling mode while the heart is experiencing a selected cardiac event of known diagnosis and the basket structure 20 is retained in a fixed location in the region 12.
  • the selected event comprises an arrhythmia that the physician seeks to treat, for example, ventricular tachycardia (VT) , or atrial tachycardia (AT) , or atrial fibrillation (AF) .
  • VT ventricular tachycardia
  • AT atrial tachycardia
  • AF atrial fibrillation
  • the signal processing module 50 processes the electro- gram morphologies obtained from each electrode during the known cardiac event (designated for the purpose of illustration as El to E3 in Fig. 4A) .
  • the electrograms may be recorded unipolar (between an electrode 24 and a reference electrode, not shown) or bipolar (between electrodes 24 on the structure 20) .
  • the host processor 52 creates a digital, event- specific template for the morphology sensed at each electrode (designated for the purpose of illustra- tion as Tl to T3 in Fig. 4A) .
  • the event-specific templates Tl to T3 for each electrode El to E3 can be based upon electrogram morphology from one heart beat or a specified number of heart beats.
  • the event-specific template Tl to T3 for each electrode El to E3 can be created by, for example, having the physician manually select representative electrogram morphologies.
  • the template preferably comprises one heart beat and is updated beat by beat. Also preferably, though not essential, the starting point of the template should coincide with the beginning of the depolarization and extend one beat from that point. However, if the arrhythmia event under study is polymorphic, it may be necessary to extend the template over several beats. For example, in bigeminy cases, the template should preferably extend over two beats.
  • the host processor 52 retains the set of event- specific templates Tl to T3 in memory.
  • the processor 52 can, for an individual patient, retain sets of event-specific templates for different cardiac events. For example, a patient may undergo different VT episodes, each with a different morphology.
  • the processor 52 can store templates for each VT episode for analysis according to the invention.
  • the templates can be downloaded to external disk memory for off-line matching at a subsequent time, as will be described later. Templates can also be generated based upon mathematical modeling or empirical data and stored for later matching for diagnostic purposes.
  • the process controller 32 operates the pacing module 48 to apply pacing signals sequentially to each of the individual elec ⁇ trodes.
  • the pacing electrode is designated Ep in Fig. 4A.
  • the pacing signal induces depolarization, emanating at the location of the pacing electrode Ep.
  • the process controller 32 operates the signal processing module 50 to process the resulting paced electrogram morphologies sensed at each electrode (again designated El to E3 for the purpose of illustration in Fig. 4A) during pacing by the selected individual electrode Ep.
  • the processed paced electrograms are designated PI to P3 in Fig. 4A.
  • the paced morphology Pi to P3 at each electrode can be from one heart beat or a specified number of heart beats, provided that the length of the mor ⁇ phologies PI to P3 is not shorter than the length of the event-specific templates Tl to T3 for the same electrodes El to E3 obtained during the sampling mode.
  • Different conventional pacing techniques can be used to obtain the paced morphologies PI to P3.
  • conventional pace mapping can be used, during which the pace rate is near the arrhythmia rate, but arrhythmia is not induced.
  • conventional entrainment or reset pacing is the pre ⁇ ferred technique.
  • the pacing rate is slightly higher than and the period slightly lower than that observed during the ar- rhythmia event, thereby increasing the rate of the induced arrhythmia event.
  • Further details of entrainment pacing are found in Almendral et al., "Entrainment of Ventricular Tachycardia: Explanation for Surface Electrocardiographic Phenomena by Analysis of Electrograms Recorded Within the Tachy ⁇ cardia Circuit," Circulation, vol. 77, No. 3, March 1988, pages 569 to 580, which is incorporated herein by reference.
  • the pacing stimulus may be monophasic, biphasic, or triphasic.
  • the host processor 52 compares the paced morphology PI to P3 obtained at each electrode El to E3 to the stored event- specific template Tl to T3 for the same electrode El to E3.
  • the comparisons (which are designated Cl to C3 in Fig. 4A) can be performed by using matched filtering or correlation functions, as will be described later.
  • the paced morphologies PI to P3 can be retained in memory or downloaded to external disk memory for matching at a later time.
  • the host processor 52 preferably includes an input module 72 for uploading pregenerated templates and/or paced morphologies recorded at an earlier time.
  • the input module 72 allows templates and paced morphologies to be matched off-line by the host processor 52, without requiring the real time presence of the patient.
  • recorded paced morphologies can be matched in real time using templates generat ⁇ ed earlier.
  • the pregenerated templates can repre ⁇ sent "typical" biopotential events based upon either real, empirical data, or mathematical models for diagnostic purposes, or reflect earlier biopotential events recorded for the same patient or for a patient having the same or similar prognosis.
  • the host processor 52 For each pacing electrode Ep(j) , the host processor 52 generates a matching coefficient M coeF ) for each electrode E(i) from the comparison C(i) of the pacing morphology P(i) to the template morpholo ⁇ gy T(i) for the same electrode E(i) .
  • both j and i 1 to n, where n is the total number of electrodes on the three dimensional structure (which, for the purpose of illustration in Fig. 4A, is 3) .
  • the value of the matching coefficient M C0EF(i) is indicative for that electrode E(i) how alike the pacing morphology P(i) is to the event-specific tem- plate T(i) for that electrode E(i) .
  • the value of Mo jgp .,. for each electrode E(i) varies as the location of the pacing electrode Ep(j) changes.
  • the value of the matching coefficient M CCEF O ) for a 9i ven electrode E(i) increases in rela ⁇ tion to the closeness of the pacing electrode Ep(j) to the arrhythmogenic foci.
  • the host processor 52 while pacing at an individual one of the electrodes Ep(j), the host processor 52 generates from the matching coefficients M ⁇ p .,-, for each electrode E(i) an overall matching factor M pACE( ) for the pacing elec ⁇ trode Ep(j) .
  • the value of the overall matching factor M pACE(j . for the pacing electrode Ep(j) is indicative of how alike the overall propagation pattern observed during pacing at the electrode Ep(j) is to the overall propagation pattern recorded on the associated event-specific templates.
  • the process controller 32 operates the pacing module 48 to apply a pacing signal sequentially to each electrode Ep(j) and processes and compares the resulting electrogram morphologies at each electrode E(i) (including Ep(j)) to the event-specific tem ⁇ plates, obtaining the matching coefficients M coe _ (j) for each electrode E(i) and an overall matching factor M pACE(J) for the pacing electrode Ep(j), and so on, until every electrode E(i) serves as a pacing electrode Ep(j).
  • M PACE(j) for eacn pacing electrode can be derived from associated matching coefficients M C0EF(j) in various ways.
  • M-, ACE ⁇ j can be computed as a first order average (arithmetic mean) of M COEF(j) as follows: ⁇ M
  • i 1 to n; or as a weighted arithmetic mean, as follows :
  • the site appropriate for ablation typically constitutes a slow conduction zone, designated SCZ in Fig. 4B.
  • Depolarization wave fronts (designated DWF in Fig. 4B) entering the slow conduction zone SCZ (at site A in Fig. 4B) break into errant, circular propaga- tion patterns (designated B and C in Fig. 4B) , called "circus motion.”
  • the circus motions disrupt the normal depolarization patterns, thereby disrupt ⁇ ing the normal contraction of heart tissue to cause the cardiac event.
  • the event-specific templates T(i) record these disrupted depolarization patterns.
  • the host processor 52 can employ pattern matching; symmetry matching; matched filter- ing; cross correlation; or norm of the difference techniques. The following provides an overview of each of these techniques.
  • Pattern Matching Fig. 5 diagrammatically shows a pattern matching technique that embodies features of the invention.
  • the pattern matching technique matched filters the template T(i) for each electrode E(i) using the same template flipped left to right with respect to time, Tflip(i), as coefficients of the matched filter.
  • Fig. 6B shows a representative template T(i) for a given electrode E(i) .
  • Fig. 6C shows Tflip(i) , which is the template T(i) (shown in Fig. 6B) flipped right to left.
  • Fig. 6E shows a matched fil- tered output MT(i) , which had T(i) (Fig. 6B) as input and Tflip(i) (Fig. 6C) for the same electrode E(i) as coefficients of the matched filter.
  • the matched filtered output MT(i) is, for the electrode E(i), a sequence of alternating maxi- mums and minimums, with their values marking a first pattern employed by this technique.
  • the pattern matching technique also matched filters the paced electrogram P(i) for each elec ⁇ trode E(i) using an identical matched filter as the one described above.
  • Fig. 6A shows a representative paced electrogram P(i) for the given electrode E(i) .
  • Fig. 6D shows the matched filtered output MP(i), using Tflip(i) shown in Fig. 6C as the matched filtered coefficients.
  • the matched filtered output MP(i) is, for each electrode E(i) , a sequence of alternating maximums and minimums, which are used to construct a second pattern.
  • the pattern matching technique detects the maxi ⁇ mums and minimums for the matched filtered template outputs MT(i) and those of MP(i).
  • the pattern matching technique places the maximums and minimums in two odd-length, L-sized model vectors, with the largest excursions at position
  • the pattern matching technique computes the norm of the difference between the MP- pattern and the corresponding MT-pattern shifted by an amount, P, that varies from -K to K, where K ⁇ L/2.
  • P the maximum number of comparisons for n elec- trodes will be n comparisons for each pacing elec ⁇ trode.
  • the minimum norms of the electrodes are averaged by an appropriate weighted average algorithm (as above discussed) . This yields the overall matching factor M pAC ⁇ (j) for each pacing electrode Ep(j) , i.e.,
  • Symmetry Matching Fig. 7A shows a symmetry matching technique that embodies features of the invention.
  • the symmetry matching technique matched filters the paced electrogram P(i) for each electrode E(i) using Tflip(i) as coefficients of the matched fil ⁇ ter.
  • Each filter output is tested with respect to the largest excursion or extreme from baseline (EXC ⁇ ) , the sign (positive or negative) of EXC ⁇ , and a symmetry index (SYM) , where:
  • Similar electrograms will create a matched filtered output having a positive largest excursion. As the degree of similarity between the two electrograms increases, the matched filtered output will become increasingly more symmetric about this positive absolute maximum.
  • the scoring factors based upon SYM are converted to an overall matching factor M p ⁇ g . jj for each pacing electrode Ep(j), as previously described.
  • the pacing electrode Ep(j) creating the highest overall matching factor is designated to be close to a potential ablation site.
  • Fig. 6E shows the matched filtered output MT(i) of the template electrogram of Fig.
  • Fig. 6B shows a largest excursion that is positive and an output that is perfectly symmetric about the positive absolute maximum.
  • a perfect scoring factor M-o- p ⁇ , of 1.0 would be assigned.
  • Fig. 6D which is the matched filtered output MP(i) of the electrogram of Fig. 6A and the flipped template in Fig. 6C. These are different, yet similar electrograms.
  • the symmetry matching technique detects this close similarity.
  • Fig. 6D shows a positive largest excursion, and the output is relatively symmetric about this positive absolute maximum.
  • a good scoring factor M C0Ef(j) of, for example, 0.9 would be assigned.
  • Fig. 8C is the matched fil- tered output of the electrogram of Fig. 6A using the flipped template shown in Fig. 8B as coefficient of the matched filter. It can be seen that the elec ⁇ trogram shown in Fig. 8A has a morphology quite different than that shown in Fig. 6A. The symmetry matching technique detects this difference. Fig. 8C shows a negative largest excursion and an output that is not symmetric about this absolute maximum. A poor scoring factor M C0EF( ) of zero would be as ⁇ signed. 3. Matching against Dirac Pulse
  • Fig. 9 shows a technique matching against Dirac pulse that embodies features of the invention.
  • This matching technique employs a whitening algorithm to first filter the template electrograms and the paced electrograms.
  • the whitening filter transforms so-called colored noise, which can be 60- Hz (or 50-Hz) interference, or motion or muscular artifacts of the patient, to white noise.
  • the technique matched filters the whitened paced electrogram for each electrode using the left-right flipped, whitened template for that electrode as coefficients of the matched filter. Ideally, exactly matched, whitened electrograms will produce an output that equals a Dirac pulse. Therefore, each filter output is compared to a Dirac pulse. An algorithm scores the similarity for each electrode.
  • the pacing electrode whose whitened, matched filtered output most closely resembles a Dirac pulse is designated to be close to a potential ablation site.
  • Cross Correlation Technique Fig. 10 shows a cross correlation technique that embodies features of the invention.
  • This technique uses an appropriate algorithm to calculate for each electrode the cross correlation function between the template electrogram and the paced electrogram. For identical electrograms, the largest excursion of the cross correlation function will equal 1.0.
  • Various conventional methods for determining the cross correlation function can be used. For exam ⁇ ple, for M pairs of data ⁇ x(m), y(m) ⁇ , where x(m) is the template electrogram and y(m) is the paced electrogram, the correlation function can be calcu- lated as follows: j ⁇ j ⁇ jrj .
  • m 1 to M; -M ⁇ k ⁇ M, and x and y are the means of the sequences ⁇ x ⁇ and ⁇ y ⁇ .
  • the pacing electrode Ep(j) having an overall matching factor M pACE(j . closest to 1.0 is designated to be close to a potential ablation site. Additional information may be contained in the shift parameter k for each electrode.
  • Fig. 11A shows the cross correla ⁇ tion function for the electrograms of Fig. 6A and Fig. 6B. These electrograms are quite similar, and the cross correlation technique detects this.
  • the largest excursion of the cross correlation function in Fig. 11A is near 1.0 (i.e., it is 0.9694).
  • Fig. 11B shows the cross correlation function for the unlike electrograms shown in Figs. 6A and 8A.
  • the cross correlation technique detects this lack of similarity.
  • the largest excursion in Fig. 11B is negative (i.e., it is -0.7191) .
  • Fig. 12 shows a norm of the difference technique that embodies features of the invention.
  • This technique normalizes, for each electrode, the template electrogram with respect to the abso ⁇ lute value of its largest excursion from baseline. This technique also normalizes, for each electrode, the paced electrogram with respect to the largest excursion from baseline. The technique then calcu ⁇ lates, for each electrode, the norm of the differ ⁇ ence between the template electrogram and the paced electrogram. The norm will decrease in proportion to the similarity of the electrograms.
  • Fig. 13A is the difference between the similar electrograms shown in Figs. 6A and 6B, after each was normalized with respect to its largest excursion. This technique detects the similarity with a relatively small norm of the difference (i.e., it is 0.9620).
  • Fig. 13B is the difference between the dissimilar electrograms shown in Figs. 6A and 8A, after each was normalized with respect to its largest excursion. This technique detects the lack of similarity with a relatively high norm of the difference (i.e., it is 2.4972).
  • the technique preferably uses a weighted averag- ing algorithm to average, for each pacing electrode, the norm of the differences for all recording elec ⁇ trodes.
  • the pacing electrode having the smallest average norm of the differences is designated the appropriate place to ablate.
  • the electrograms may or may not be filtered before analysis. A 1 to 300 Hz bandpass filter may be used for filtering. If a filter is used to reduce the noise for an electrogram that is used as a template, the same filter must also be used for the paced electrograms, since filtering may alter the electrogram morphology.
  • the electrograms might need to be aligned prior to processing. Any columnar alignment technique can be used. For example, the electrograms could be aligned about the point of largest positive slope.
  • the implementation of the system 10 described herein is based largely upon digital signal process ⁇ ing techniques. However, it should be appreciated that a person of ordinary skill in this technology area can easily adapt the digital techniques for analog signal processing.
  • an analog matched filter can be implemented with analog integrators and adders.
  • optical realizations of such filters can be implemented, for example, by using optical slots to represent the template. After optical conversion, the input signal is passed through the optical slot. The average light intensity behind the optical slot plane is maximal when the shape of the optically converted input signal matches the shape of the slot.
  • An optical sensor can measure the average light intensity and output a signal that represents the matched coefficient M COEF(i) .
  • the host processor 52 sets a match target N Match , which numerically estab ⁇ lishes a matching factor pACE(J) at which a high probability exists that the pacing electrode is close to a potential ablation site.
  • N ⁇ 0.8.
  • the host processor 52 deems the location of the pacing electrode Ep(j) to be close to a potential site for ablation. When this occurs (as Fig. 4 shows), the host processor 52 transmits a SITE signal to an associated output display device 54 (see Fig. 1A) . Through visual prompts, the display device 54 notifies the physician of the location of the pacing electrode Ep(j) and suggests that the location as a potential ablation site.
  • the host processor 52 sorts to locate the M pACE(J) having the highest value. In this instance, the host processor 52 deems the pacing electrode Ep(j) with the highest M pAC£(j) to be the one having the highest likelihood for being close to a potential ablation site and transmits the SITE signal accordingly.
  • the process controller 32 provides iterative pacing and matching using different pacing and matching tech ⁇ niques. Using different pacing-and-compare tech ⁇ niques allows the comparison of the location output from one technique with the location output from one or more different techniques. Using iterative pacing and matching, the process controller 32 and the host processor 52 confirm and cross-check the location output to verify its accuracy before ablation. The host processor 52 can also rely upon alternative diagnostic techniques to analyze the biopotential morphology. In the illustrated and preferred embodiment (see
  • the system 10 also includes a roving pacing probe 68 usable in tandem with the basket structure 20 to generate and verify the location output.
  • the process controller 32 includes a module 60 that allows the physician to select among different types of pacing techniques.
  • the different pacing techniques allow the physician to conduct both global and localized site identification, with and without inducing the abnormal cardiac event.
  • At least one technique is appropriate for pacing a large tissue region to identify a subregion close to a potential ablation site, without the need to induce an abnormal cardiac event.
  • the process controller 32 first conditions the pacing module 48 in the mode to conduct pace mapping. Pace mapping uses all elec ⁇ trodes 24 on the structure 20 in sequence as the pacing electrode, and does not induce the cardiac event. Based upon pace mapping, the process control ⁇ ler 32 obtains a location output that points to a general subregion that is close to a potential ablation site.
  • the process controller 32 conditions the pacing module 48 in the matching mode to carry out entrainment or reset pacing, using the electrodes in the general subregion as the pacing electrodes. Entrainment or reset pacing in this subregion overdrives the arrhythmia, and provides enhanced differentiation of slow conduction zones. The process controller 32 thereby obtains a location output that is more localized with respect to the potential ablation site.
  • the process controller 32 also includes a module 62 that allows the physician to select more than one matching technique during iterative pacing.
  • the process controller 32 may, during pace mapping or entrainment/reset pacing, compare the templates to the paced electrograms by first pattern matching, then by symmetry matching, and then by norm of the difference. In this way, the process controller 32 determines the uniformity of the location output among the different matching techniques. The correspondence of the location outputs confirms their reliability. 3. Cross-Check Using Alternative Diagnostics.
  • the process con ⁇ troller 32 is also electrically coupled by a bus 64 to a diagnostic module 66.
  • the diagnostic module 66 conducts one or more alternative analyses of heart activity to cross check or verify the output location that the process controller 32 generates based upon electrogram matching.
  • the module 66 determines the fractionation of the paced electrograms.
  • the degree of fractionation can be used as a cross-check that the physician can employ to cross-check and verify the output location or locations that the process controller 32 yields when operated in the matching mode.
  • the location output may comprise a single electrode 24 or several electrodes 24 in a localized region of the structure 20.
  • the system 10 further includes a roving pacing probe 68 that can be deployed in the heart region 12 while the multiple electrode structure 20 occupies the region 12.
  • the roving probe 68 is electrically coupled to the pacing module 48 to emit pacing signals.
  • the physician positions the roving electrode probe 68 within the localized region near the output location electrode or elec- trodes 24.
  • the process controller 32 preferably includes a homing module 70 to aid the physician in guiding the roving electrode probe 68 in the local ⁇ ized region within the structure 20.
  • Systems and methods for operating the homing module 70 are dis- closed in copending patent application Serial No. 08/320,301, filed October 11, 1994, and entitled “Systems and Methods for Guiding Movable Electrode Elements Within Multiple Electrode Structures", which is incorporated herein by reference.
  • the process controller 32 conditions the pacing module 48 to emit pacing signals through the roving pacing probe 68 to pace the heart in the localized region, while the electrodes 24 record the resulting electrograms.
  • the process controller 32 By pacing this localized region with the roving pacing probe 68, while comparing the paced electrograms with the templates, the process controller 32 provides the capability of pacing and comparing at any location within the structure 20. In this way, the process controller 32 generates as output a location indicator that locates a site as close to a potential ablation site as possible.
  • iterative pacing and matching techniques can be practiced using the roving pacing probe 68. Due to the often convoluted and complex contours of the inside surface of the heart, the basket structure 20 cannot contact the entire wall of a given heart chamber.
  • the preferred implementation of the system 10 (as Fig.
  • the roving pacing probe 68 therefore deploys the roving pacing probe 68 outside the structure to pace the heart in those wall regions not in contact with the electrodes 24.
  • the roving pacing probe 68 can also be deployed while the basket structure 20 occupies the region 12 to pace the heart in a different region or chamber.
  • the electrodes 24 on the structure 20 record the resulting paced electrograms for comparison by the process controller 32 to the templates.
  • the process controller 32 is thus able to generate an output identifying a location close to a potential ablation site, even when the site lies outside the structure 20 or outside the chamber that the structure 20 occupies.
  • the physician deploys the ablation electrode 36 to the location of the pacing electrode Ep(j) to conduct the ablation (as Fig. 1A shows) .
  • the homing module 70 (as already described and as shown in Fig. IB) can also be used to aid the physician in deploying the ablation elec- trode 36 to the designated site, as disclosed in copending patent application Serial No. 08/320,301, filed October 11, 1994, and entitled “Systems and Methods for Guiding Movable Electrode Elements Within Multiple Electrode Structures", which is incorporated herein by reference.
  • the system 10 is not limited to the diagnosis and treatment of arrhythmia events.
  • the system 10 can be used in the sampling mode, for example, to create templates while the heart is in sinus rhythm.
  • the heart In the matching mode, the heart can be paced at sinus rhythm rates and the paced electrograms compared to the templates to detect abnormal activation patterns associated with other forms of heart disease or to identify the presence of accessory pathways.
  • the template electrograms at all electrodes 24 are recorded during the same time interval.
  • the pacing electrograms for each pacing electrode Ep(j) are recorded at all electrodes 24 during the same time interval. This technique requires the process controller 32 to have parallel processing channels equal in number to the number of electrodes 24 conditioned to record the electrograms.
  • the process controller 32 must be capable of handling thirty-two (32) parallel channels of information.
  • the process controller 32 can be operated in a time-sequential recording mode.
  • the process control ⁇ ler 32 records electrograms, either to create a template or to create paced electrograms for match ⁇ ing, at different time intervals.
  • the process controller 32 consolidates the time-sequen ⁇ tial electrograms for composite analysis, as if the electrograms were recorded during the same time intervals.
  • the time-sequential mode can be used when the waveshapes of the electrograms to be analyzed are generally the same during each heart beat. For example, monomorphic VT is characterized by such time-invariant electrogram waveshapes.
  • the time- sequential mode allows the physician to condition the process controller 32 to record time invariant electrograms in numbers greater than the number of processing channels that the process controller 32 has.
  • the process controller 32 can only accommodate twenty (20) channels of data at a given time, the time-sequential mode nevertheless allows information from thirty-two (32) electrograms to be recorded and processed.
  • Fig. 21 shows the time-sequential mode of operation in diagrammatic flow chart form.
  • the time-sequential mode simultaneously records electrograms at first elec ⁇ trode sites ES(1).
  • the first electrode sites ES(1) number twenty (20) and are designated E(l) to E(20) .
  • the electrograms for the first site electrodes E(l) to E(20) are retained for the first time interval TI(1).
  • Fig. 22A shows representative electrograms recorded at E(l) during TI(1).
  • Fig. 22B shows a representative electrogram recorded at E(2) during TI(1) .
  • the time- sequential mode simultaneously records electrograms at second electrode sites, at least one of which is an electrode site used during the first time inter- val TI(1).
  • Fig. 21 identifies E(l) as the common electrode site.
  • E(21) to E(32) comprise the remain ⁇ ing electrodes in ES(2) .
  • Fig. 22C shows representa ⁇ tive electrograms recorded at the common electrode site E(l) during TI(2).
  • Fig. 22D shows representa- tive electrograms recorded at the additional elec ⁇ trode site E(21) during TI(2).
  • the time-sequential mode determines the time difference TD between the electrograms for E(l) at TI(1) and TI(2).
  • Fig. 22C shows TD.
  • Fig. 23C shows the representative electrograms recorded at E(l) during TI(2) after time-alignment with the electrograms recorded at E(l) during TI(1), which are shown in Fig. 23A.
  • the time-sequential mode also left-shifts the electrograms E(21) through E(32) by the same amount TD.
  • Fig. 23D shows the representative electrograms recorded at E(21) during TI(2) after time-alignment.
  • the time-sequential mode creates the electrogram composite EC, which consists of the time-registered electrograms E(l) to E(32) taken at TI(1) and TI(2).
  • the time-alignment process of creating the electrogram composite EC can be done manually by the physician, by interacting with the display device 54.
  • the host processor 52 automatically analyzes the signals, computes TD, and accomplishes the time-alignment to create the composite electrogram EC.
  • TD need not be computed.
  • the physician or the operator can make use of any time-assignment method to align the signals based on the information contained in the common channels E(l) .
  • An example of useful informa- tion is the location of the maximal slopes of E(l) .
  • this algorithm can be automatically implemented and executed.
  • the time-aligned electrogram composite EC can be analyzed in the same manner as electrograms taken simultaneously during the same time interval.
  • the electrogram composite EC can be used to create the electrogram template, or to create paced electrograms for comparison with an electrogram template, or as electrograms for any other diagnos ⁇ tic purpose.
  • the endocardially positioned basket structure 20 both paces and senses the resulting electrograms.
  • the process controller 32 can condition the pacing module 48 in the sampling mode to pace the heart to induce a desired cardiac event, using individual or pairs of electrodes 24 on the basket structure 20 deployed in the heart region 12 (as already described) , while creating templates of the resulting electrocardiograms recorded by the processing module 50 from body surface electrodes electrically coupled to the process controller 32.
  • the process controller 32 paces the heart with the individual or pairs of endocardial electrodes 24 positioned on the structure 20 in the heart region
  • the resulting paced electrocardiograms are recorded by the same body surface electrodes (locat ⁇ ed in the same position as during the sampling mode) and compared to the electrocardiogram templates in the manner above described.
  • the process controller 32 generates the location output based upon compar ⁇ ing the electrocardiogram sample templates with endocardially paced electrocardiograms.
  • Electrocardiogram Time Delays Endocardially paced electrocardiograms can also be used to identify regions of slow conduction.
  • the process controller 32 conditions the pacing module 48 to pace the heart with the individual or pairs of electrodes 24 positioned on the structure 20 endocardially in the heart region 12, the resulting endocardially paced electrocardiograms are recorded by body surface electrodes coupled to the process controller 32. From the endocardially paced elec ⁇ trocardiograms, the process controller 32 measures the time difference between the pacing signal and the onset of the Q-wave to detect slow conduction regions (characterized by abnormally large time delays) .
  • the process controller 32 generates maps displaying iso-time delay regions based upon these endocardially paced electrocardiograms, to further aid in the location of the slow conduction region.
  • Time delays obtained from endocardially paced electrocardiograms can also characterize heart tissue morphology.
  • the body surface elec ⁇ trodes record electrocardiograms while the pacing module 48 paces the heart with the individual or pairs of electrodes 24 positioned on the structure 20 in the heart region 12.
  • the pacing module 48 first paces the heart at or near normal sinus rhythm rates.
  • the process controller 32 registers the time delays recorded from the resulting electrocardio ⁇ grams.
  • the pacing module 48 next paces the heart at an increased rate, e.g., at or near an arrhythmia rate.
  • the process controller 32 registers the resulting time delays from the resulting electro- cardiograms.
  • the process controller 32 compares the paced sinus rate time delays with the paced arrhythmia rate time delay.
  • the location of the pacing elec ⁇ trodes where the time delays shortened as the pacing rate increased are near regions of healthy tissue.
  • the location of pacing electrodes where the time delays lengthened as the pacing rate increased are near regions of ischemic tissue.
  • the process controller 32 preferably generates iso-display maps showing the distribution of the time delay differ ⁇ ences, thereby aiding the physician in differentiat ⁇ ing between regions of healthy and ischemic tissue.
  • Pacing artifacts in the pacing electrograms may be eliminated by conventional techniques to better discern the initial point of depolarization. Howev ⁇ er, in the illustrated and preferred embodiment, the process controller 32 includes a filter 56 (see Fig. 4) that removes the pacing artifact for this purpose without otherwise altering the morphology of the electrogram. The operation of the filter 56 may vary. ⁇ . nonlinear Filter
  • the filter 56 implements a nonlinear sorting algorithm of the type shown in Fig. 14A.
  • Fig. 14B shows a representative implementation and filter output for the algorithm in diagrammatic form.
  • the algorithm establishes a sample window.
  • the sample window has a predetermined length (WL) , ex ⁇ pressed in terms of the number of discrete sample points the window contains.
  • the predetermined length (WL) of the sample window takes into account the length (AL) of the pacing artifact, which is ex ⁇ pressed in terms of the number of sample points that encompass the pacing artifact.
  • the window length WL is an odd number.
  • WL is significantly smaller than twice AL, the sorting algorithm will not serve to eliminate the pacing artifact to the extent necessary to accurately discern the initial point of depolariza ⁇ tion. There is, however, a limitation placed upon how large WL is relative to the size of AL. When WL is significantly larger than twice AL, the morpholo ⁇ gy of the electrogram will be distorted by being spread out with respect to time.
  • the algorithm sorts the sample values X(n) in the window from smallest value to largest value.
  • the algorithm outputs the sample value X(p[f]) contained in the selected sort position, which constitutes the filter output for the boxcar sample.
  • the algorithm outputs X(p[f]) and advances the window forward in time one sample point.
  • the algorithm repeats the sorting process, generating a filter output for each boxcar sample and advancing the window, until the entire electro ⁇ gram has been processed.
  • the algorithm then plots the filter outputs with respect to time, which constitutes the filtered electrogram.
  • EXAMPLE Nonlinear Filtering
  • the algorithm sorts the sequence X(l to 5) in increasing numerical value, or
  • the algorithm establishes the sort positions p(n) based upon this permutation, or
  • the algorithm selects a sort position p(f) according to prescribed criteria.
  • the criteria for selecting the sort position takes into account the length of the artifact AL, as will be discussed later.
  • the criteria specifies the sort position relative to the other sort positions.
  • (f) is ex ⁇ pressed as a position (z) of WL positions, i.e., p(z/WL), where WL is the size of the sort window.
  • the position z is selected taking into account AL, and, more particularly, z should increase as AL decreases.
  • p(3/5) means that X(p(3)) replaces x(3) in the output se ⁇ quence.
  • the value X(p(3)) is 6, which becomes the filter output for this boxcar sample, based upon the selected sort position criteria.
  • p(3/5) criteria actual ⁇ ly implements a median filter. For a given window, the following sort position z constitutes the median
  • the value X(p(4)) is 8, which becomes the nonlinear, non-median filter output for this boxcar sample, based upon the selected sort position criteria. This corresponds to x(4) of the output sequence.
  • the algorithm advances the window one sample at a time, sorting the sample enclosed within the window, and generating a filter output based upon the sort criteria, and so on until the entire electrogram has been filtered.
  • the algorithm keeps the timing of filter output in sequence with the timing of the electrogram by retaining the value of edge samples, so that the number of filter outputs equal the number of electrogram samples.
  • the number of edge values retained depends upon the size of the sample window WL.
  • the algorithm retains a prescribed number, y. , of beginning sample values a number, y 2 , of ending sample values, arranging the filter output between the prescribed number of beginning and ending sample values to keep the filter output arranged with respect to time in sequence with the derived biological signal.
  • y x z- ⁇
  • Fig. 14B shows the filtering of ten sample points (4 2 7 5 1 10 3 8 9 6) in accordance with the above described technique.
  • the window length WL in Fig. 14B is 5, and the sort criteria is median filtering, i.e. p(3/5) .
  • Fig. 14B also shows the filter outputs (4 5 5 5 8 8) between the edge samples, with the sorted samples appearing to the right of the filter outputs.
  • FIG. 14C shows the filtering of the same ten sample points (4 2 7 5 1 10 3 8 9 6), with the same window length WL of 5, but with a non-median sort criteria p(4/5) .
  • Fig. 14C shows the filter output for the p(4/5)-criteri ⁇ on: (5 7 7 8 9 9) between the edge samples.
  • Fig. 15A shows a simulated pacing artifact where AL is 5 and the width of the highest peak is 3.
  • Fig. 15B shows the filtered output for p(2/5) ;
  • Fig. 15C shows the filtered output for the median, or p(3/5); and
  • Fig. 15D shows the filtered output for p(4/5).
  • Fig. 16A shows a simulated pacing artifact where AL is 5 and the width of the highest peak is 2.
  • Fig. 16B shows the filtered output for p(2/5);
  • Fig. 16C shows the filtered output for p(3/5), i.e. the median; and
  • Fig. 16D shows the filtered output for p(4/5) .
  • the criteria p(3/5) fully eliminated the pacing artifact (Fig. 16C)
  • the criteria p(2/5) and p(4/5) did not (Figs. 16B and 16D, respectively) .
  • Fig. 17A shows a simulated pacing artifact where AL is 5 and the width of the highest peak is 1.
  • Fig. 17B shows the filtered output for p(2/5) ;
  • Fig. 17C shows the filtered output for p(3/5) , i.e. the median; and
  • Fig. 17D shows the filtered output for p(4/5).
  • the criteria p(4/5) fully eliminated the pacing artifact (Fig. 17D)
  • the criteria p(2/5) and p(3/5) did not (Figs. 17B and 17C, respectively) .
  • Fig. 18A shows a paced electrogram consisting of 500 samples taken in increments of 0.5 seconds.
  • Fig. 18C shows a reduction in the size but not an elimination of the pacing artifact PA by median filtering.
  • Fig. 18B shows an elimination of the pacing artifact by median filtering. Except for the median filter p(3/5) , the imple ⁇ mentation of this type of nonlinear filter will distort both the positive and negative phases of the useful signal (see Figs. 15B/D, 16B/D, and 17B/D.) B.
  • the filter 56 can implement the adaptive filtering algorithm shown in Fig. 19 to remove the pacing artifact.
  • the filter 56 generates an internal variable TPACE(t) expressing a template of the pacing arti- fact itself.
  • the function TPACE(t) preferably begins with a preestablished template typical for a pacing artifact.
  • the algorithm can create an initial template by manually selecting a window about the artifact and creating a template by, for example, conventional signal averaging techniques. This template could be adaptively updated using appropriate signal averaging techniques.
  • Figs. 24 to 28 exemplify a preferred way of generating a template of the pacing artifact.
  • Fig. 24 shows a portion of a recording of a paced elec ⁇ trogram extending over about two beats and a half.
  • Fig. 24 shows three pacing pulses (PA-1; PA-2; PA- 3) , which are the artifacts that are to be ultimate ⁇ ly removed.
  • PA-1 pacing pulses
  • PA-2 PA-2
  • PA- 3 three pacing pulses
  • the physician preferably selects windows about each pacing pulse PA-1 to 3 to create an averaged template.
  • the physician can select one of the pacing pulse, for example PA- 1, to generate the template.
  • Figs. 25A to C represent the signals PS-1; PS-2; and PS-3 contained by the three windows manually selected about the pacing pulses, respectively PA-1; PA-2; and PA-3.
  • the physician manually aligns the three signals PS-1; PS-2; and PS-3 and truncates them at the same length, as Figs. 26A to C show.
  • the three signals PS-l; PS-2; and PS-3 have been aligned about their largest positive peak, although other alignment techniques could be used.
  • Fig. 27 shows the template TPACE(t) of the pacing artifact generated by averaging the three signals PS-1; PS-2; and PS-3 after alignment and truncation (i.e., the signals shown in Figs. 26A to C are averaged) .
  • the template TPACE(t) (Fig. 28B) is aligned with the first pacing pulse in the electrogram (Fig. 28A) prior to executing the adaptive algorithm for artifact removal.
  • TPACE(t) It is not necessary to generate a new pacing artifact template TPACE(t) for the electrogram sensed by each electrode.
  • the same initial template TPACE(t) from only one of the electrodes can be used for every electrogram.
  • pacing signals from different electrodes can be aligned for averag ⁇ ing to create the template TPACE(t) , which is then used for all electrograms.
  • the template TPACE(t) can also be generated by approximating the pacing pulse using suitable mathematical techniques, for example, spline inter ⁇ polation.
  • a universal template TPACE(t) can also be generated from recordings taken from different patients at different times with different equip ⁇ ment, although such different records may require proper adjustment before generating the universal template TPACE(t) .
  • the filter 56 expresses the input signal with respect to time IN(t) in term of the function expressed as:
  • PACE(t) is the pacing artifact.
  • the template TPACE(t) of the filter 56 reduces IN(t), so the output signal EG(t) is expressed as IN(t) - TPACE(t).
  • the filter 56 changes TPACE(t) over time based upon the energy of the output EG(t) so as to minimize the energy of (PACE(t) - TPACE(t)) over time, and therefore, the energy of EG(t) .
  • the filter 56 seeks to minimize the function EG(t) + PACE(t) - TPACE(t) over time.
  • the energy of EG(t) is mini ⁇ mized over time when TPACE(t) equals PACE(t) , therefore being equal to the energy of EG(t) .
  • the filter algorithm changes TPACE(t) over time applying known iterative techniques.
  • LMS Least-Mean-Squares
  • the template for TPACE(t) is used as a refer ⁇ ence input for the LMS algorithm.
  • the weight vector is initialized at [K 0 0 ... 0] .
  • K is chosen equal to the ratio between the peak of PACE(t) and the peak of the template TPACE(t) .
  • PACE(t) TPACE(t)
  • k is equal to one. Further details of LMS are found in "Adaptive Filter Theory" by S. Haykin (Prentice Hall, 1991)
  • Fig. 20A shows a representative paced electro ⁇ gram.
  • the designation PA in Fig. 20A marks the location of the pacing artifact.
  • Fig. 2OB shows the paced electrogram after filtering using the LMS technique above described.
  • Fig. 2OB shows the effectiveness of the adaptive filter to remove the pacing artifact, without otherwise altering the morphology of the paced electrogram.
  • Either of the above described techniques for removing the pacing artifact have application outside the conditioning of the electrogram for morphology matching described herein.
  • Either tech- nique has application whenever it is desired to remove an artifact signal from a useful signal or to otherwise eliminate virtually any signal of a known shape.
  • nonlinear filter ⁇ ing or adaptive filtering can be used whenever it is desired to remove cardiac related or other periodic artifacts, for example, in respiratory signals, or EEG's, or from neurological signals.
  • Nonlinear filtering or adaptive filtering can also be used to eliminate periodic artifacts that are not cardiac related, for example, 50 to 60 Hz noise from sensed signals due to poor power source isolation.
  • nonlinear filtering or adaptive filtering can also be used to remove the pacing artifact before measuring the level of fractionation in an electrogram. Since a pacing artifact looks much like an electrogram, it is desirable to remove it before analyzing for actual fractionation.
  • nonlinear filtering or adap ⁇ tive filtering can be used to remove a pacing artifact when it is desired to conduct a frequency domain analysis of the cardiac signal, to determine the regularity of the heart beat.
  • any portion of the electrogram can be isolated for elimination using the filtering techniques de ⁇ scribed above, not merely the pacing artifact.
  • the nonlinear and adaptive filtering techniques can be used in applications where low pass filtering cannot be used.
  • body surface mapping can use low pass filtering of electrograms
  • endocar- dial mapping cannot, due to the use of higher fre ⁇ quencies than in electrocardiograms.
  • a common electrocardiogram frequency spectrum is .05 to 100 Hz
  • a common bipolar electrogram spectrum is l to 300 Hz.
  • Nonlinear filtering or adaptive filtered can be used for processing or analyzing virtually any signal derived from a biological event.
  • nonlinear filter or adaptive filtering can be used to process or analyze electroencephalograms, respiratory signals, electrogastrograms, and electromyograms.

Abstract

Systèmes et procédés d'acquisition d'électrocardiogrammes à l'aide d'une première électrode (24) associée à une région du tissu cardiaque et d'une seconde électrode située à la surface du corps. Un élément de traitement analogique ou numérique (32) est couplé à la première et la seconde électrode de sorte que la première soit conditionnée pour émettre un signal de stimulation (48) et que la seconde soit conditionnée pour détecter les électrocardiogrammes stimulés résultant du signal de stimulation. On utilise également dans les systèmes et procédés selon l'invention un modèle d'électrocardiogramme d'un événement cardiaque de diagnostic connu, tel qu'une arythmie que le médecin cherche à traiter. Ce modèle spécifique à un événement est comparé à un échantillon d'électrocardiogramme stimulé. La comparaison permet de produire un coefficient de correspondance indiquant le degré de similitude entre l'échantillon d'entrée et le modèle d'entrée. Le coefficient de correspondance peut être utilisé par le médecin pour, par exemple, faciliter la localisation de sites potentiellement appropriés à l'ablation (46).
PCT/US1996/002092 1995-02-17 1996-02-16 Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules WO1996025096A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39054995A 1995-02-17 1995-02-17
US08/393,158 1995-02-17
US08/393,158 US5711305A (en) 1995-02-17 1995-02-17 Systems and methods for acquiring endocardially or epicardially paced electrocardiograms
US08/390,549 1995-02-17

Publications (2)

Publication Number Publication Date
WO1996025096A1 true WO1996025096A1 (fr) 1996-08-22
WO1996025096A9 WO1996025096A9 (fr) 1996-10-24

Family

ID=27013189

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/002092 WO1996025096A1 (fr) 1995-02-17 1996-02-16 Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules

Country Status (1)

Country Link
WO (1) WO1996025096A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0848965A2 (fr) * 1996-12-17 1998-06-24 Pacesetter, Inc. Procédé et système pour la comparaison de la morphologie de formes d'ondes
CN102885648A (zh) * 2012-08-29 2013-01-23 中国人民解放军第三军医大学第一附属医院 肾脏去交感神经消融导管系统
CN102885649A (zh) * 2012-08-29 2013-01-23 中国人民解放军第三军医大学第一附属医院 肾脏去交感神经射频线控消融导管系统
US8521266B2 (en) 2008-10-09 2013-08-27 The Regents Of The University Of California Methods for the detection and/or diagnosis of biological rhythm disorders
US8676303B2 (en) 2008-05-13 2014-03-18 The Regents Of The University Of California Methods and systems for treating heart instability
US9220427B2 (en) 2011-05-02 2015-12-29 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9241667B2 (en) 2010-04-08 2016-01-26 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
GB2529200A (en) * 2014-08-13 2016-02-17 Richard C Saumarez Improvement to analysing physiological electrograms
WO2016024082A1 (fr) * 2014-08-13 2016-02-18 Saumarez Richard C Appareil d'enregistrement et d'analyse d'un électrocardiogramme (ecg) de surface pour distinguer un signal physiologique d'un bruit
US9398883B2 (en) 2011-05-02 2016-07-26 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9468387B2 (en) 2011-05-02 2016-10-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
CN106456009A (zh) * 2014-06-20 2017-02-22 波士顿科学医学有限公司 用于映射心脏组织的医疗装置
US9655535B2 (en) 2011-05-02 2017-05-23 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
DE102016011700A1 (de) 2016-09-28 2018-03-29 Personal Medsystems Gmbh Überwachung von Biosignalen, insbesondere Elektrokardiogrammen
US10030961B2 (en) 2015-11-27 2018-07-24 General Electric Company Gap measuring device
US10058262B2 (en) 2011-12-09 2018-08-28 The Regents Of The University Of California System and method of identifying sources for biological rhythms
US10085655B2 (en) 2013-03-15 2018-10-02 The Regents Of The University Of California System and method to define drivers of sources associated with biological rhythm disorders
US10398326B2 (en) 2013-03-15 2019-09-03 The Regents Of The University Of California System and method of identifying sources associated with biological rhythm disorders
US10434319B2 (en) 2009-10-09 2019-10-08 The Regents Of The University Of California System and method of identifying sources associated with biological rhythm disorders

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5311873A (en) * 1992-08-28 1994-05-17 Ecole Polytechnique Comparative analysis of body surface potential distribution during cardiac pacing
US5323781A (en) * 1992-01-31 1994-06-28 Duke University Methods for the diagnosis and ablation treatment of ventricular tachycardia
US5391199A (en) * 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US5485849A (en) * 1994-01-31 1996-01-23 Ep Technologies, Inc. System and methods for matching electrical characteristics and propagation velocities in cardiac tissue
US5487391A (en) * 1994-01-28 1996-01-30 Ep Technologies, Inc. Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5323781A (en) * 1992-01-31 1994-06-28 Duke University Methods for the diagnosis and ablation treatment of ventricular tachycardia
US5311873A (en) * 1992-08-28 1994-05-17 Ecole Polytechnique Comparative analysis of body surface potential distribution during cardiac pacing
US5391199A (en) * 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
US5487391A (en) * 1994-01-28 1996-01-30 Ep Technologies, Inc. Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart
US5485849A (en) * 1994-01-31 1996-01-23 Ep Technologies, Inc. System and methods for matching electrical characteristics and propagation velocities in cardiac tissue

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0848965A3 (fr) * 1996-12-17 1999-06-09 Pacesetter, Inc. Procédé et système pour la comparaison de la morphologie de formes d'ondes
EP0848965A2 (fr) * 1996-12-17 1998-06-24 Pacesetter, Inc. Procédé et système pour la comparaison de la morphologie de formes d'ondes
US8676303B2 (en) 2008-05-13 2014-03-18 The Regents Of The University Of California Methods and systems for treating heart instability
US10136860B2 (en) 2008-05-13 2018-11-27 The Regents Of The University Of California System for detecting and treating heart instability
US11147462B2 (en) 2008-10-09 2021-10-19 The Regents Of The University Of California Method for analysis of complex rhythm disorders
US8521266B2 (en) 2008-10-09 2013-08-27 The Regents Of The University Of California Methods for the detection and/or diagnosis of biological rhythm disorders
US10092196B2 (en) 2008-10-09 2018-10-09 The Regents Of The University Of California Method for analysis of complex rhythm disorders
US9955879B2 (en) 2008-10-09 2018-05-01 The Regents Of The University Of California System for analysis of complex rhythm disorders
US10434319B2 (en) 2009-10-09 2019-10-08 The Regents Of The University Of California System and method of identifying sources associated with biological rhythm disorders
US9549684B2 (en) 2010-04-08 2017-01-24 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US10856760B2 (en) 2010-04-08 2020-12-08 The Regents Of The University Of California Method and system for detection of biological rhythm disorders
US9241667B2 (en) 2010-04-08 2016-01-26 The Regents Of The University Of California System and method for reconstructing cardiac signals associated with a complex rhythm disorder
US9913615B2 (en) 2011-05-02 2018-03-13 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9220427B2 (en) 2011-05-02 2015-12-29 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US10149622B2 (en) 2011-05-02 2018-12-11 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9655535B2 (en) 2011-05-02 2017-05-23 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US9668666B2 (en) 2011-05-02 2017-06-06 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9468387B2 (en) 2011-05-02 2016-10-18 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US9398883B2 (en) 2011-05-02 2016-07-26 The Regents Of The University Of California System and method for reconstructing cardiac activation information
US10485438B2 (en) 2011-05-02 2019-11-26 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US10058262B2 (en) 2011-12-09 2018-08-28 The Regents Of The University Of California System and method of identifying sources for biological rhythms
CN102885648A (zh) * 2012-08-29 2013-01-23 中国人民解放军第三军医大学第一附属医院 肾脏去交感神经消融导管系统
CN102885649A (zh) * 2012-08-29 2013-01-23 中国人民解放军第三军医大学第一附属医院 肾脏去交感神经射频线控消融导管系统
CN102885648B (zh) * 2012-08-29 2015-03-18 中国人民解放军第三军医大学第一附属医院 肾脏去交感神经消融导管系统
US11446506B2 (en) 2013-03-15 2022-09-20 The Regents Of The University Of California System and method of identifying sources associated with biological rhythm disorders
US10398326B2 (en) 2013-03-15 2019-09-03 The Regents Of The University Of California System and method of identifying sources associated with biological rhythm disorders
US10098560B2 (en) 2013-03-15 2018-10-16 The Regents Of The University Of California System and method to identify sources associated with biological rhythm disorders
US10085655B2 (en) 2013-03-15 2018-10-02 The Regents Of The University Of California System and method to define drivers of sources associated with biological rhythm disorders
US10271744B2 (en) 2013-03-15 2019-04-30 The Regents Of The University Of California System and method to identify sources associated with biological rhythm disorders
CN106456009A (zh) * 2014-06-20 2017-02-22 波士顿科学医学有限公司 用于映射心脏组织的医疗装置
US10368767B2 (en) 2014-06-20 2019-08-06 Boston Scientific Scimed Inc. Medical devices for mapping cardiac tissue
US10349852B2 (en) 2014-08-13 2019-07-16 Fen EP, Ltd. Analysing physiological electrograms
GB2529200B (en) * 2014-08-13 2019-05-01 Fen Ep Ltd Improvement to Analysing Physiological Electrograms
GB2529200A (en) * 2014-08-13 2016-02-17 Richard C Saumarez Improvement to analysing physiological electrograms
WO2016024082A1 (fr) * 2014-08-13 2016-02-18 Saumarez Richard C Appareil d'enregistrement et d'analyse d'un électrocardiogramme (ecg) de surface pour distinguer un signal physiologique d'un bruit
CN106999042A (zh) * 2014-08-13 2017-08-01 芬埃普有限公司 记录和分析体表心电图(ecg)以区分生理信号与噪声的设备
US10030961B2 (en) 2015-11-27 2018-07-24 General Electric Company Gap measuring device
WO2018060162A1 (fr) 2016-09-28 2018-04-05 Personal Medsystems Gmbh Surveillance de signaux biologiques, en particulier d'électrocardiogrammes
DE102016011700A1 (de) 2016-09-28 2018-03-29 Personal Medsystems Gmbh Überwachung von Biosignalen, insbesondere Elektrokardiogrammen

Similar Documents

Publication Publication Date Title
US5711305A (en) Systems and methods for acquiring endocardially or epicardially paced electrocardiograms
US5595183A (en) Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5722416A (en) Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites
US6101409A (en) Systems and methods for analyzing biopotential morphologies in body tissue
US5630425A (en) Systems and methods for adaptive filtering artifacts from composite signals
US5609157A (en) Systems and methods for analyzing biopotential morphologies in body tissue using iterative techniques
US5795303A (en) Systems and methods for making time-sequential measurements of biopotentials sensed in myocardial tissue
US5601088A (en) Systems and methods for filtering artifacts from composite signals
US5605157A (en) Systems and methods for filtering signals derived from biological events
WO1996025095A9 (fr) Systemes et procedes de prise de mesures a deroulement chronologique d'evenements biologiques
US5792064A (en) Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation
US5954661A (en) Tissue characterization and treatment using pacing
US5759158A (en) Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
WO1996025096A1 (fr) Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules
WO1996025096A9 (fr) Acquisition d'electrocardiogramme endocardiaques ou epicardiaques stimules
US6088614A (en) Tissue characterization to identify an ablation site
US9579064B2 (en) Medical devices for mapping cardiac tissue
JP2021186685A (ja) オートエンコーダを使用する心内心電図のノイズ削減、並びに深層学習訓練損失関数を使用する心内及び身体表面心電図の利用及び精緻化
WO1996025094A1 (fr) Systemes et procedes d'analyse de morphologies de biopotentiel dans des tissus du corps
WO1996025093A1 (fr) Systemes et procedes pour filtrer des signaux derives d'evenements biologiques
EP4032471A1 (fr) Détermination automatique de stabilité de cathéter
US20230181087A1 (en) Intracardiac unipolar far field cancelation using multiple electrode cathethers
EP4014871A1 (fr) Mesure et affichage automatiques d'intervalle de post-stimulation
JP2022001256A (ja) オートエンコーダを使用した心室遠距離場推定
CN114652315A (zh) 经由来自生理信号的近场识别改进心脏标测

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/34-7/34,9/34-23/34 AND 25/34-34/34,DRAWINGS,REPLACED BY NEW PAGES BEARING THE SAME NUMBER;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase